Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Mar 14;19(5):3685–3695. doi: 10.3892/mmr.2019.10033

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © Cai et al.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PMC Copyright notice

Figure 3. — χ² correlation of clinicopathological characteristics and CTC count with the Tif1γ plasma levels. (A) A significant correlation was observed between the CTC count and the Tif1γ plasma levels in the breast cancer patients. The number of CTC count-positive patients was 67.2±6.2% in the Tif1γ-negative group and 46.2±7.0% in the Tif1γ-positive group. (B) Statistically significant correlations were observed between the tumor size and (C) tumor stage and the Tif1γ plasma levels. (D-I) No significant correlation was observed with histological grade, lymph node status, ductal/invasive type, molecular subtype, Her2 status and age. CTC, circulating tumor cell; Tif1γ, transcription intermediary factor 1 γ; Her2, human epidermal growth factor receptor 2.